Treace Medical Concepts, Inc.
TMCI
$3.93
-$0.13-3.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 47.20M | 62.52M | 50.21M | 47.39M | 52.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.20M | 62.52M | 50.21M | 47.39M | 52.57M |
| Cost of Revenue | 9.79M | 12.12M | 10.51M | 9.64M | 10.68M |
| Gross Profit | 37.41M | 50.40M | 39.71M | 37.75M | 41.89M |
| SG&A Expenses | 49.95M | 51.78M | 49.70M | 49.23M | 51.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 64.37M | 68.44M | 64.89M | 64.36M | 68.15M |
| Operating Income | -17.17M | -5.92M | -14.68M | -16.97M | -15.58M |
| Income Before Tax | -17.96M | -9.39M | -16.29M | -17.40M | -15.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.96M | -9.39M | -16.29M | -17.40M | -15.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.96M | -9.39M | -16.29M | -17.40M | -15.92M |
| EBIT | -17.17M | -5.92M | -14.68M | -16.97M | -15.58M |
| EBITDA | -16.27M | -4.11M | -11.90M | -14.40M | -13.12M |
| EPS Basic | -0.28 | -0.15 | -0.26 | -0.28 | -0.25 |
| Normalized Basic EPS | -0.17 | -0.07 | -0.15 | -0.17 | -0.16 |
| EPS Diluted | -0.28 | -0.15 | -0.26 | -0.28 | -0.25 |
| Normalized Diluted EPS | -0.17 | -0.07 | -0.15 | -0.17 | -0.16 |
| Average Basic Shares Outstanding | 64.59M | 63.86M | 63.52M | 63.01M | 62.66M |
| Average Diluted Shares Outstanding | 64.59M | 63.86M | 63.52M | 63.01M | 62.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |